News

Vancouver, British Columbia, Canada– Andira Pharmaceuticals welcomes to its board of directors, Dr. Ethan Russo, a global pioneer in the development of cannabinoid therapeutics. Andira is a privately-held biopharmaceutical firm dedicated to the advancement of cannabinoid-based therapeutics for infectious disease and oncology indications in the traditional pharmaceutical business model. Andira

Vancouver, British Columbia, Canada– To protect novel anti-infective formulations developed at The University of British Columbia (UBC) for the treatment of Enterococcus, including the multi-drug-resistant superbug VRE, a Patent Cooperation Treaty (PCT) application entitled “Antibiotic Cannabinoid-Terpene Formulations” was filed in May 2020. The International Search Report & Written Opinion (ISR/WO)